Letter to the editor: pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical pharmacology 2010-09, Vol.66 (9), p.959-960
Hauptverfasser:	Mercier, Cédric, Dahan, Laetitia, Ouafik, L’Houcine, André, Nicolas, Ciccolini, Joseph
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenine Antimetabolites, Antineoplastic - administration & dosage Antimetabolites, Antineoplastic - pharmacokinetics Biomedical and Life Sciences Biomedicine Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - metabolism Confounding Factors (Epidemiology) Cytidine Deaminase - genetics Cytosine Deoxycytidine - administration & dosage Deoxycytidine - analogs & derivatives Deoxycytidine - pharmacokinetics Humans Letter to the Editors Lung Neoplasms - drug therapy Lung Neoplasms - metabolism Pharmacology/Toxicology Polymorphism, Genetic Polymorphism, Single Nucleotide Research Design
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!